Abstract
Blood dyscrasias associated with levetiracetam use can be difficult to identify, especially when other potential differential diagnoses are concurrently present. Here we present a 57-year-old man with metastatic adenocarcinoma of unknown primary origin on levetiracetam who initially presented with an in-stent thrombosis of the right external iliac vein and then developed worsening thrombocytopenia followed by pancytopenia. Levetiracetam was not identified as the culprit until other causes like platelet consumption, heparin-induced thrombocytopenia, idiopathic immune thrombocytopenic purpura, and bone marrow involvement by metastatic disease were ruled out.
Author supplied keywords
Cite
CITATION STYLE
Din, M. A. U., Hussain, S. A., & Bodrog, A. (2021). Delayed recognition of levetiracetam-induced pancytopenia. European Journal of Case Reports in Internal Medicine, 8(3). https://doi.org/10.12890/2021_002449
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.